Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $94.96 million. The enterprise value is $101.73 million.

Market Cap	94.96M
Enterprise Value	101.73M

Important Dates

The next estimated earnings date is Thursday, November 20, 2025, before market open.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

ESLA has 37.07 million shares outstanding. The number of shares has increased by 34.72% in one year.

Current Share Class	37.07M
Shares Outstanding	37.07M
Shares Change (YoY)	+34.72%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	2.16%
Owned by Institutions (%)	1.72%
Float	10.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	198.26%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-636
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +190.47% in the last 52 weeks. The beta is 0.39, so ESLA's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+190.47%
50-Day Moving Average	1.39
200-Day Moving Average	1.09
Relative Strength Index (RSI)	79.16
Average Volume (20 Days)	367,068

Short Selling Information

The latest short interest is 29,615, so 0.08% of the outstanding shares have been sold short.

Short Interest	29,615
Short Previous Month	26,333
Short % of Shares Out	0.08%
Short % of Float	0.27%
Short Ratio (days to cover)	0.17

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.08M
Pretax Income	-12.08M
Net Income	-12.08M
EBITDA	n/a
EBIT	-12.08M
Earnings Per Share (EPS)	-$0.33

Full Income Statement

Balance Sheet

The company has $1.32 million in cash and $4,000 in debt, giving a net cash position of $1.31 million or $0.04 per share.

Cash & Cash Equivalents	1.32M
Total Debt	4,000
Net Cash	1.31M
Net Cash Per Share	$0.04
Equity (Book Value)	-6.09M
Book Value Per Share	-0.16
Working Capital	-7.59M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.72%
Shareholder Yield	-34.72%
Earnings Yield	-11.73%
FCF Yield	n/a

Analyst Forecast

The average price target for ESLA is $16.00, which is 524.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	524.51%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1